| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090616A1 Fat cell differentiation regulator |
| 08/31/2006 | WO2006090275A1 Treatment of incontinence |
| 08/31/2006 | WO2006090047A1 Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases |
| 08/31/2006 | WO2006073572A3 Treatment of conditions caused by calcium abnormalities |
| 08/31/2006 | US20060194872 Diamine derivative, production process therefor and antioxidant |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194862 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency |
| 08/31/2006 | US20060194850 methyl 3-(4-{4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-isoxazolyl}-benzylsulfanyl)propionate; compounds inhibit the physiological activity of lysophosphatidic acid (LPA); treatment of fibrosis of organs (liver, kidney, lung, and the like), hepatic disease |
| 08/31/2006 | US20060194822 Treatment for renal fibrosis |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194757 urinary tract incfections; for instillation to bladder |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060194742 Pyrane derivatives as both ACE- and NEP-inhibitors |
| 08/31/2006 | US20060194738 Cytomodulating peptides for treating interstitial cystitis |
| 08/31/2006 | US20060194736 Polypeptide for the treatment of cancer and a method for preparation thereof |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060193929 Method for treating or preventing symptoms associated with menopause |
| 08/31/2006 | CA2599151A1 Novel quinoline derivatives as potassium ion channel openers |
| 08/31/2006 | CA2597802A1 Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases |
| 08/30/2006 | EP1695982A1 Glycosylation-deficient hepatocyte growth factor |
| 08/30/2006 | EP1695698A1 Anti-angiogene compositions and methods of use |
| 08/30/2006 | EP1695697A1 Anti-angiogenic compositions and methods of use |
| 08/30/2006 | EP1694664A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1383772B1 Nitrogen-based camptothecin derivatives |
| 08/30/2006 | EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 08/30/2006 | CN1824664A Novel quinuclidine derivatives and medicinal compositions containing the same |
| 08/30/2006 | CN1824260A Medicine for treating disease due to kidney yang vacuity |
| 08/30/2006 | CN1824239A Quality control method of kidney beneficial bone fortifying capsule |
| 08/30/2006 | CN1824214A Chinese medicine for treating calculus of urinary system |
| 08/30/2006 | CN1824206A Medicine for treating gonorrhoea |
| 08/30/2006 | CN1824205A Medicine for treating chronic prostatitis and its preparation method |
| 08/30/2006 | CN1824178A Chinese medicinal preparation for treating urinary system disease, its preparation method and quality control method |
| 08/30/2006 | CN1824165A Medicine kidney maintenance |
| 08/30/2006 | CN1824155A Medicine used for kidney supplementing and its preparation method |
| 08/30/2006 | CN1824126A Quality control method of oral preparation for yin enriching kidney supplementing |
| 08/30/2006 | CN1824121A Yin enriching kidney supplementing medicinal preparation and its new preparation method |
| 08/30/2006 | CN1824033A Kidney supplementing blood nourishing preparation and its making method |
| 08/30/2006 | CN1824016A Compound flowery knotweed and rehmannia preparation and its manufacturing method |
| 08/30/2006 | CN1823980A Chinese medicinal preparation for treating chronic prostatitis and its manufacturing method |
| 08/30/2006 | CN1823979A Medicinal tablet for treating prostate disease and its preparation method |
| 08/30/2006 | CN1823974A Tablet for treating prostatauxe and its preparation method |
| 08/30/2006 | CN1823932A Oral liquid for eliminating dropsy and improving kidney function |
| 08/30/2006 | CN1823912A Antiphlogistic medicine |
| 08/30/2006 | CN1823904A Compound formula Chinese lobelia vein injection liquid, its preparation method and medicine infusion way |
| 08/30/2006 | CN1823871A Chinese medicinal preparation for treating prostatitis and its preparation method |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823758A Compounds and methods of treating transplant rejection |
| 08/30/2006 | CN1272334C Quinuclidine derivs. as muscarinic M3 receptors ligand and their use |
| 08/30/2006 | CN1272332C Red clover total flavone high content extract, preparation and application in pharmaceutical combination thereof |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 08/30/2006 | CN1272045C Wolfberry fruit-astragalus root oral liquid and its prepn process |
| 08/30/2006 | CN1272027C Desmodium preparation for treating urinary calculus, infection and cholelithiasis cholecy stolithiasis and chole cystitis and its production method |
| 08/30/2006 | CN1271999C Use of extracts and preparations from iris plants and tectorigenin as organ selective medicament for treating urethra disease |
| 08/30/2006 | CN1271946C Preparation method of edible nutritious health powder for lithiasis patients |
| 08/29/2006 | US7098246 Esterified hydroxytyrosol; 2-(3,4-dihydroxyphenyl)ethyl acetate for example |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098229 (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2006 | US7098214 Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders |
| 08/29/2006 | US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens |
| 08/29/2006 | US7098207 Imidazotriazinones and the use thereof |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2201785C New carboxylic acid derivatives, their preparation and their use |
| 08/24/2006 | WO2006089230A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/24/2006 | WO2006088784A1 Use of estrogen receptor-b selective agonists for radiation-or chemotherapy-induced mucosistis and radiation cystitis |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088075A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative |
| 08/24/2006 | WO2006088011A1 Inhibitor of plasminogen activator inhibitor-1 |
| 08/24/2006 | WO2006063178A3 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 08/24/2006 | WO2006043858A3 Method for cleaning the internal environment of an organism and endoecological correction agent |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060191024 Method for preparing anti-MIF antibodies |
| 08/24/2006 | US20060189673 Phenylazole compound, production process therefor and antioxidant |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189615 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 08/24/2006 | US20060189597 Lactam compounds and pharmaceutical use thereof |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | US20060188990 Novel prostate tumor-specific promoter |
| 08/24/2006 | US20060188554 Transdermal absorption preparation |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | CA2598522A1 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/24/2006 | CA2596984A1 Use of estrogen receptor-beta selective agonists for radiation-or chemotherapy-induced mucositis and radiation cystitis |
| 08/23/2006 | EP1693374A1 Microcrystal and medicinal preparation containing the same |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693369A1 Protein modifier production inhibitor |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692129A1 Keto lactam compounds and use thereof |
| 08/23/2006 | EP1485391B1 Phosphate transport inhibitors |
| 08/23/2006 | EP1363920B1 Modified psma ligands and uses related thereto |
| 08/23/2006 | EP1358318B1 Hybridoma cell line g250 and its use for producing monoclonal antibodies |